- About Us
- Advisory Board
- Editorial
- Contact Us
- Advertise
- Contact MJH LS
- Do Not Sell My Information
- Terms and Conditions
- Privacy
© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Top Medical News
Alzheimer Disease Agent Lecanemab Shows Reduction in CDR-Sum of Boxes in Clarity AD
September 28, 2022
By Matt Hoffman
The investigational treatment from Eisai and Biogen significantly reduced the Clinical Dementia Rating-Sum of Boxes scores among patients with early AD, with safety and ARIA-E and ARIA-H incidence as expected.
Acupuncture Proves Effective as Method to Improve Sleep Quality for Post-Stroke Insomnia
September 27, 2022
By Isabella Ciccone, MPH
In a randomized controlled trial, results demonstrated that acupuncture is to be efficacious in improving insomnia, quality of life, and affective symptoms for patients with ischemic stroke.
Unraveling the Roots of ALS Through Reactivation of HERVs and Antibody Levels
September 27, 2022
By Marco Meglio
Avindra Nath, MD, clinical director of the National Institute of Neurological Disorders and Stroke, provided insight on new findings that may explain the symptoms of certain cases of sporadic ALS.
Virtual Reality Training May Improve Quality of Care in Lower Limb Spasticity With OnabotulinumtoxinA
September 27, 2022
By Isabella Ciccone, MPH
Results from pilot program using a VR-based platform suggest medical trainees may benefit from further VR training to gain a complete baseline knowledge of treating lower limb spasticity with onabotulinumtoxinA.
Long-Term Safety of MS Treatment Ofatumumab Confirmed in ALITHIOS Extension
September 27, 2022
By Marco Meglio
Over a 3.5-year treatment period, the risk of serious infections or malignancies, few of which were previously reported, did not increase with additional ofatumumab exposure.
.jpg?w=900&fit=crop&auto=format)
